BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35461289)

  • 1. Increasing uptake to a lung cancer screening programme: building with communities through co-design.
    Brown LR; Sullivan F; Treweek S; Haddow A; Mountain R; Selby C; Beusekom MV
    BMC Public Health; 2022 Apr; 22(1):815. PubMed ID: 35461289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context.
    Quinn-Scoggins HD; Murray RL; Quaife SL; Smith P; Brain KE; Callister MEJ; Baldwin DR; Britton J; Crosbie PAJ; Thorley R; McCutchan GM
    BMC Pulm Med; 2022 Dec; 22(1):478. PubMed ID: 36522781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
    Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
    BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening.
    Simmons VN; Gray JE; Schabath MB; Wilson LE; Quinn GP
    Lung Cancer; 2017 Apr; 106():42-49. PubMed ID: 28285693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging the Mammography Setting to Raise Awareness and Facilitate Referral to Lung Cancer Screening: A Qualitative Analysis.
    Eberth JM; Ersek JL; Terry LM; Bills SE; Chintanippu N; Carlos R; Hughes DR; Studts JL
    J Am Coll Radiol; 2020 Jul; 17(7):960-969. PubMed ID: 32112723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms.
    Holland-Hart D; McCutchan GM; Quinn-Scoggins HD; Brain K; Hill L; Shanbag S; Abel M; White K; Evans A; Rees S; Bowen S; Gemine R; Collier G
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
    Li J; Chung S; Wei EK; Luft HS
    BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a Lung Cancer Screening Program in Two Federally Qualified Health Centers.
    Watson L; Cotter MM; Shafer S; Neloms K; Smith RA; Sharpe K
    Public Health Rep; 2021; 136(4):397-402. PubMed ID: 33440129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Personalized Risk Information on Patients Referred for Lung Cancer Screening with Low-Dose CT.
    Han PKJ; Lary C; Black A; Gutheil C; Mandeville H; Yahwak J; Fukunaga M
    Med Decis Making; 2019 Nov; 39(8):950-961. PubMed ID: 31631776
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center.
    Lewis JA; Petty WJ; Tooze JA; Miller DP; Chiles C; Miller AA; Bellinger C; Weaver KE
    Cancer Epidemiol Biomarkers Prev; 2015 Apr; 24(4):664-70. PubMed ID: 25613118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer screening implementation: Complexities and priorities.
    Rankin NM; McWilliams A; Marshall HM
    Respirology; 2020 Nov; 25 Suppl 2():5-23. PubMed ID: 33200529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and Facilitators Impacting Lung Cancer Screening Uptake Among Black Veterans: A Qualitative Study.
    Navuluri N; Lanford T; Shapiro A; Krishnan G; Johnson AB; Riley IL; Zullig LL; Cox CE; Shofer S
    J Natl Compr Canc Netw; 2024 Apr; 22(4):231-236. PubMed ID: 38640946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening.
    Wernli KJ; Tuzzio L; Brush S; Ehrlich K; Gao H; Anderson ML; Palazzo L
    Perm J; 2021 Jun; 25():. PubMed ID: 35348073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
    Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
    Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding patient barriers and facilitators to uptake of lung screening using low dose computed tomography: a mixed methods scoping review of the current literature.
    Cavers D; Nelson M; Rostron J; Robb KA; Brown LR; Campbell C; Akram AR; Dickie G; Mackean M; van Beek EJR; Sullivan F; Steele RJ; Neilson AR; Weller D
    Respir Res; 2022 Dec; 23(1):374. PubMed ID: 36564817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piloting electronic screening forms in primary care: findings from a mixed methods study to identify patients eligible for low dose CT lung cancer screening.
    O'Brien MA; Sullivan F; Carson A; Siddiqui R; Syed S; Paszat L
    BMC Fam Pract; 2017 Nov; 18(1):95. PubMed ID: 29179686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to participate in the colorectal cancer screening programme in Flanders (Belgium): a focus group study.
    Hoeck S; Van Roy K; Willems S
    Acta Clin Belg; 2022 Feb; 77(1):37-44. PubMed ID: 32552612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.